Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation
Authors:
- Tao LiTLTao Li
- Zhiqiang LiuZLZhiqiang Liu
- Kesheng JiangKJKesheng Jiang
- Qin RuanQRQin Ruan
- 1 September 2013
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 337 (2) , 276-284
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Angiopoietins 1 and 2 and Tie‐2 receptor expression in human ductal breast diseaseHistopathology, 2011
- Angiopoietin‐2 drives lymphatic metastasis of pancreatic cancerThe FASEB Journal, 2011
- Specifically Targeting Angiopoietin-2 Inhibits Angiogenesis, Tie2-Expressing Monocyte Infiltration, and Tumor GrowthClinical Cancer Research, 2011
- Angiopoietin-2 Promotes Disease Progression of Neuroendocrine TumorsClinical Cancer Research, 2010
- Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosisEndocrine-Related Cancer, 2009
- Angiopoietin-2 Serum Levels Are Elevated in Patients With Liver Cirrhosis and Hepatocellular CarcinomaAmerican Journal of Gastroenterology, 2007
- Angiopoietin: A TIE(d) Balance in Tumor AngiogenesisMolecular Cancer Research, 2007
- Angiopoietins in malignancyEuropean Journal of Surgical Oncology, 2007
- Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumorsJournal of the American College of Surgeons, 2004
- Biologic significance of angiopoietin-2 expression in human hepatocellular carcinomaJournal of Clinical Investigation, 1999